The Duty to Disclose Adverse Clinical Trial Results

American Journal of Bioethics 9 (8):24-32 (2009)
  Copy   BIBTEX

Abstract

Participants in some clinical trials are at risk of being harmed and sometimes are seriously harmed as a result of not being provided with available, relevant risk information. We argue that this situation is unacceptable and that there is a moral duty to disclose all adverse clinical trial results to participants in clinical trials. This duty is grounded in the human right not to be placed at risk of harm without informed consent. We consider objections to disclosure grounded in considerations of commercial interest, and we argue that these concerns are insufficient to override the moral duty to disclose adverse clinical trial results. However, we also develop a proposal that enables commercial interests to be protected, while promoting the duty to disclose adverse clinical trial results.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 74,569

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

The Duty to Disclose (Even More) Adverse Clinical Trial Results.Nicole Hassoun - 2009 - American Journal of Bioethics 9 (8):33-34.

Analytics

Added to PP
2009-01-28

Downloads
137 (#90,289)

6 months
3 (#210,812)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Steve Clarke
Charles Sturt University

References found in this work

Principles of Biomedical Ethics.Tom L. Beauchamp - 1979 - New York: Oxford University Press.
The Morality of Freedom.Joseph Raz - 1986 - Oxford University Press.
.Daniel Kahneman & Shane Frederick - 2002 - Cambridge University Press.
The Morality of Freedom.Joseph Raz - 1986 - Philosophy 63 (243):119-122.
Choices, Values, and Frames.Daniel Kahneman & Amos Tversky (eds.) - 2000 - Cambridge University Press.

View all 19 references / Add more references